Neuro-Behcet Disease (CNS Involvement in Behcet Disease)

Overview

• Bradley and Daroff's Neurology, p. 1227

Epidemiology and Risk Factors

• CNS involvement occurs in approximately 20% of Behcet patients overall
• In children and adolescents, the incidence of neuro-Behcet ranges from 5% to 15%
• Males predominate among those with neuro-Behcet, especially in pediatric populations
• In a large Turkish cohort of 728 patients, 3.6% were pediatric; pediatric patients were more likely to have venous sinus thrombosis (88.5%) than parenchymal brain disease (11%), which contrasts with adults
• Disease is more common in Turkey and other Middle Eastern countries
• Neurological involvement is a cause of major morbidity; approximately 50% of patients are moderately to severely disabled after 10 years
• Bradley and Daroff's Neurology, p. 1228; Grainger & Allison's Diagnostic Radiology, p. 1524

Pathophysiology

1. Small vessel inflammatory disease - causing ischemia of brain and spinal cord
2. Vasculitis of both arterial and venous systems - associated with thrombosis and arterial aneurysms
3. Chronic meningoencephalitis - the most common pathological pattern of CNS involvement
4. Dural sinus thrombosis - particularly cerebral venous sinus thrombosis (CVST)

• Grainger & Allison's Diagnostic Radiology; Bradley and Daroff's Neurology

Clinical Presentations

Parenchymal Neuro-Behcet (most common form in adults)

Psychiatric Manifestations

• Depression, psychosis, dementia - part of the recognized neuro-psychiatric spectrum

Vascular Neuro-Behcet

• Cerebral venous sinus thrombosis (CVST) - more common in pediatric patients
• Intracranial hemorrhage - secondary to ruptured aneurysms (rare)
• Ischemic stroke - from small vessel inflammatory vasculopathy

Spinal Cord

• Myelopathy can occur (cord lesions visible on MRI)

Peripheral Nervous System (rare)

• Polyneuropathy or mononeuropathy multiplex
• In neuro-otological presentation: vestibular neuronitis
• Rare case reports of facial nerve paralysis and vocal cord paralysis
• Bradley and Daroff's Neurology; Grainger & Allison's Diagnostic Radiology, p. 1524

Diagnosis

Clinical Criteria

• Recurrent genital ulcerations
• Ocular lesions (uveitis or retinal vasculitis)
• Skin lesions (erythema nodosum, pseudofolliculitis, papulopustular lesions, acneiform nodules)
• Positive pathergy test (skin hyperreactivity to a needle prick)

CSF Findings

• Mild pleocytosis (lymphocytic)
• Elevated protein concentration
• Normal or mildly elevated opening pressure

MRI Findings (key imaging modality)

• Inflammatory parenchymal lesions - typically reversible, located in:
  • Brainstem (most characteristic)
  • Extension to the diencephalon
  • Basal ganglia
  • Periventricular and subcortical white matter
• Lesions can occasionally resemble MS plaques
• Brainstem atrophy in chronic/advanced cases
• CVST changes on MRV

Sagittal MRI in Behcet disease showing spinal cord lesion (arrows). - Grainger & Allison's Diagnostic Radiology, p. 1524

Differential Diagnosis

• Multiple sclerosis (lesions can overlap on MRI; look for oral/genital ulcers)
• Neurosarcoidosis
• CNS lupus (SLE)
• Antiphospholipid antibody syndrome
• CNS lymphoma
• Cavernous angioma with repeated bleeds
• Primary angiitis of the CNS (PACNS)
• Bradley and Daroff's Neurology; Adams and Victor's Principles of Neurology, 12th ed.

Treatment

Acute / Parenchymal Disease

• Corticosteroids are first-line - oral or IV prednisolone until clinical improvement
• High-dose IV methylprednisolone for severe acute attacks

Maintenance / Immunosuppressive Therapy

Cerebral Venous Sinus Thrombosis

• Anticoagulation is the standard treatment for CVST complicating Behcet disease
• EULAR guidelines recommend immunosuppression for thrombosis management in addition to anticoagulation
• Bradley and Daroff's Neurology, p. 1228; Murray & Nadel's Respiratory Medicine; Braunwald's Heart Disease

Key Distinguishing Points for Neuro-Behcet

1. Brainstem predominance - unlike most other vasculitides, Behcet has a predilection for the brainstem
2. Lesions are often reversible - especially with early immunosuppression, unlike MS which tends to leave permanent damage
3. CVST is more common in younger patients - especially pediatric and adolescent males
4. Pathergy test positivity supports the diagnosis in the right clinical context
5. Eye involvement (uveitis, retinal vasculitis) frequently accompanies CNS disease

Recent Evidence (PubMed 2023-2026)

• A 2023 clinical update review (PMID 37345389) on neuro-Behcet covers diagnostic and treatment updates
• A 2025 review on uncommon non-MS CNS demyelinating disorders (PMID 40591029) includes Behcet as a key differential in demyelinating-like presentations